CIGB-552: Anticancer peptide with multimodal mechanisms and clinical promise for colorectal cancer
Despite advances in chemotherapy and targeted therapy, resistance and systemic toxicity limit the clinical efficacy of current treatments of colorectal cancer (CRC).Purpose of the study. To analyze published experimental studies on the peptide drug CIGB‑552, which targets COMMD1, and its potential u...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2025-06-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/1125 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|